115 related articles for article (PubMed ID: 11113637)
1. A study of the binding requirements of calyculin A and dephosphonocalyculin A with PP1, development of a molecular recognition model for the binding interactions of the okadaic acid class of compounds with PP1.
Volter KE; Embrey KJ; Pierens GK; Quinn RJ
Eur J Pharm Sci; 2001 Jan; 12(3):181-94. PubMed ID: 11113637
[TBL] [Abstract][Full Text] [Related]
2. A molecular basis for different interactions of marine toxins with protein phosphatase-1. Molecular models for bound motuporin, microcystins, okadaic acid, and calyculin A.
Bagu JR; Sykes BD; Craig MM; Holmes CF
J Biol Chem; 1997 Feb; 272(8):5087-97. PubMed ID: 9030574
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the complex between calyculin A and the catalytic subunit of protein phosphatase 1.
Kita A; Matsunaga S; Takai A; Kataiwa H; Wakimoto T; Fusetani N; Isobe M; Miki K
Structure; 2002 May; 10(5):715-24. PubMed ID: 12015153
[TBL] [Abstract][Full Text] [Related]
4. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases.
Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE
Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro binding of microcystin to protein phosphatases 1 and 2A.
Runnegar M; Berndt N; Kong SM; Lee EY; Zhang L
Biochem Biophys Res Commun; 1995 Nov; 216(1):162-9. PubMed ID: 7488083
[TBL] [Abstract][Full Text] [Related]
6. The binding mode of calyculin A to protein phosphatase-1. A novel spiroketal vector model.
Lindvall MK; Pihko PM; Koskinen AM
J Biol Chem; 1997 Sep; 272(37):23312-6. PubMed ID: 9287341
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhibitors of protein phosphatase 1 and 2A on erythroid colony formation: an investigation of the specificities of inhibitors.
Zhang W; Tamura J; Sakuraya M; Naruse T; Kubota K
J Int Med Res; 2001; 29(2):114-8. PubMed ID: 11393344
[TBL] [Abstract][Full Text] [Related]
8. A molecular modeling analysis of the binding interactions between the okadaic acid class of natural product inhibitors and the Ser-Thr phosphatases, PP1 and PP2A.
Gauss CM; Sheppeck JE; Nairn AC; Chamberlin R
Bioorg Med Chem; 1997 Sep; 5(9):1751-73. PubMed ID: 9354231
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.
Resjö S; Oknianska A; Zolnierowicz S; Manganiello V; Degerman E
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):839-45. PubMed ID: 10417351
[TBL] [Abstract][Full Text] [Related]
10. Molecular enzymology underlying regulation of protein phosphatase-1 by natural toxins.
Holmes CF; Maynes JT; Perreault KR; Dawson JF; James MN
Curr Med Chem; 2002 Nov; 9(22):1981-9. PubMed ID: 12369866
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying inhibition of protein phosphatases by marine toxins.
Dawson JF; Holmes CF
Front Biosci; 1999 Oct; 4():D646-58. PubMed ID: 10502549
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein.
Takai A; Sasaki K; Nagai H; Mieskes G; Isobe M; Isono K; Yasumoto T
Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):657-65. PubMed ID: 7702557
[TBL] [Abstract][Full Text] [Related]
13. A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.
Gupta V; Ogawa AK; Du X; Houk KN; Armstrong RW
J Med Chem; 1997 Sep; 40(20):3199-206. PubMed ID: 9379439
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor-1 interaction domain that mediates the inhibition of protein phosphatase-1.
Connor JH; Quan HN; Ramaswamy NT; Zhang L; Barik S; Zheng J; Cannon JF; Lee EY; Shenolikar S
J Biol Chem; 1998 Oct; 273(42):27716-24. PubMed ID: 9765309
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of an archaeal protein phosphatase activity by okadaic acid, microcystin-LR, or calyculin A.
Oxenrider KA; Rasche ME; Thorsteinsson MV; Kennelly PJ
FEBS Lett; 1993 Oct; 331(3):291-5. PubMed ID: 8397116
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure and mutagenesis of a protein phosphatase-1:calcineurin hybrid elucidate the role of the beta12-beta13 loop in inhibitor binding.
Maynes JT; Perreault KR; Cherney MM; Luu HA; James MN; Holmes CF
J Biol Chem; 2004 Oct; 279(41):43198-206. PubMed ID: 15280359
[TBL] [Abstract][Full Text] [Related]
17. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.
Suganuma M; Fujiki H; Furuya-Suguri H; Yoshizawa S; Yasumoto S; Kato Y; Fusetani N; Sugimura T
Cancer Res; 1990 Jun; 50(12):3521-5. PubMed ID: 2160320
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 1 regulation by inhibitors and targeting subunits.
Watanabe T; Huang HB; Horiuchi A; da Cruze Silva EF; Hsieh-Wilson L; Allen PB; Shenolikar S; Greengard P; Nairn AC
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3080-5. PubMed ID: 11248035
[TBL] [Abstract][Full Text] [Related]
19. Phospho-pivot modeling predicts specific interactions of protein phosphatase-1 with a phospho-inhibitor protein CPI-17.
Matsuzawa F; Aikawa SI; Ohki SY; Eto M
J Biochem; 2005 May; 137(5):633-41. PubMed ID: 15944417
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction between DARPP-32 and protein phosphatase 1 (PP-1): DARPP-32 peptides antagonize the interaction of PP-1 with binding proteins.
Kwon YG; Huang HB; Desdouits F; Girault JA; Greengard P; Nairn AC
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3536-41. PubMed ID: 9108011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
